TNGX - Tango Therapeutics director buys company stock worth $2.45M
2023-10-12 15:09:10 ET
More on Tango Therapeutics
- Tango Therapeutics: Partial Phase 1 Data Has Not Helped
- Seeking Alpha’s Quant Rating on Tango Therapeutics
- Historical earnings data for Tango Therapeutics
For further details see:
Tango Therapeutics director buys company stock worth $2.45M